Status | Study |
Completed |
Study Name: Safety and Immune Response of Novartis MenACWY-CRM Conjugate Vaccine When Given to Healthy Toddlers Condition: Meningococcal Infections Date: 2008-02-20 Interventions: Biological: MenACWY-CRM + MMRV |
Completed |
Study Name: Safety and Immune Response of Novartis of MenACWY Conjugate Vaccine When Given to Healthy Children Condition: Meningococcal Infections Date: 2008-01-31 Interventions: Biological: MenACWY-CRM 1 inje |
Completed |
Study Name: Evaluation of Meningococcal ACWY Immune Response in Children Aged 40 and 60 Months Condition: Meningococcal Disease Date: 2008-01-15 Interventions: Biological: MenACWY-CRM197 Blo |
Terminated |
Study Name: B14 Meningococcal Carriage in Seine-Maritime Population: Prevalence Study and Search of Risk Factors Condition: Meningococcal Infections Date: 2007-04-24 |
Completed |
Study Name: Creation of a Biotheque of Patients of Seine-Maritime With Meningococcal Infection Condition: Meningococcal Infections Date: 2007-03-21 |
Completed |
Study Name: Safety, Tolerability and Immunogenicity of Two Different Formulations of Meningococcal B Recombinant Vaccine, When Administered to Healthy Infants Condition: Meningococcal Disease Date: 2007-02-09 Interventions: Biological: rMenB One dose (0. |
Completed |
Study Name: Immunogenicity of the Booster Dose of Two MenC Vaccines Condition: Meningococcal Infection Date: 2006-10-25 Interventions: Biological: conjugated polysaccharide menC vaccine Booster vaccine dose at 14 to 18 months. |
Completed |
Study Name: Persistence of Antibody Response to N. Meningitidis Group C in Children Condition: Prevention of Meningococcal Infection Date: 2006-04-19 Interventions: Biological: Meningococcal C conjugate vaccine |
Completed |
Study Name: Safety, Tolerability and Immunogenicity of Meningococcal C Conjugate Vaccine to Children 32 to 40 Months of Age Condition: Meningococcal Infection Date: 2006-04-03 Interventions: Biological: Meningococcal C conjugate vaccine |
Completed |
Study Name: Immunogenicity, Safety, Tolerability and Ability to Prime for Memory of Meningococcal C Conjugate Vaccine in Healthy Children Condition: Prevention of Meningococcal Infection Date: 2006-04-03 Interventions: Biological: Meningococcal C conjugate vaccine Meningococca |